相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Borreliella burgdorferi Antimicrobial-Tolerant Persistence in Lyme Disease and Posttreatment Lyme Disease Syndromes
Felipe C. Cabello et al.
MBIO (2022)
A selective antibiotic for Lyme disease
Nadja Leimer et al.
CELL (2021)
Impact of four local anaesthetics on growth and viability of in vitro cultured Borrelia burgdorferi sensu stricto, Borrelia bavariensis and Borrelia afzelii
Lucas Schorter et al.
TICKS AND TICK-BORNE DISEASES (2021)
Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31
Venkata Raveendra Pothineni et al.
SCIENTIFIC REPORTS (2020)
The Functional and Molecular Effects of Doxycycline Treatment on Borrelia burgdorferi Phenotype
John R. Caskey et al.
FRONTIERS IN MICROBIOLOGY (2019)
Blood treatment of Lyme borreliae demonstrates the mechanism of CspZ-mediated complement evasion to promote systemic infection in vertebrate hosts
Ashley L. Marcinkiewicz et al.
CELLULAR MICROBIOLOGY (2019)
Late Disseminated Lyme Disease Associated Pathology and Spirochete Persistence Posttreatment in Rhesus Macaques
Nicholas A. Crossland et al.
AMERICAN JOURNAL OF PATHOLOGY (2018)
In Vitro Antimicrobial Susceptibility of Clinical Isolates of Borrelia miyamotoi
Joris Koetsveld et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Laboratory diagnosis of Lyme borreliosis: Current state of the art and future perspectives
Benedikt Lohr et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2018)
Progress in the molecular diagnosis of Lyme disease
Eva Ruzic-Sabljic et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2017)
Published data do not support the notion that Borrelia valaisiana is human pathogenic
Gabriele Margos et al.
INFECTION (2017)
Variable manifestations, diverse seroreactivity and post-treatment persistence in non-human primates exposed to Borrelia burgdorferi by tick feeding
Monica E. Embers et al.
PLOS ONE (2017)
In vitro susceptibility of Borrelia burgdorferi isolates to three antibiotics commonly used for treating equine Lyme disease
Sanjie Caol et al.
BMC VETERINARY RESEARCH (2017)
In Vitro Susceptibility of the Relapsing-Fever Spirochete Borrelia miyamotoi to Antimicrobial Agents
Joris Koetsveld et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Borrelia bissettiae sp nov and Borrelia californiensis sp nov prevail in diverse enzootic transmission cycles
Gabriele Margos et al.
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2016)
Borrelia mayonii sp nov., a member of the Borrelia burgdorferi sensu lato complex, detected in patients and ticks in the upper midwestern United States
Bobbi S. Pritt et al.
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2016)
A divergent spirochete strain isolated from a resident of the southeastern United States was identified by multilocus sequence typing as Borrelia bissettii.
Maryna Golovchenko et al.
PARASITES & VECTORS (2016)
A tribute to Dr. Willy Burgdorfer, Medical Entomologist Extraordinaire Obituary
L. Gern et al.
TICKS AND TICK-BORNE DISEASES (2016)
A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrella burgdorferi Persisters from an FDA Drug Library
Jie Feng et al.
FRONTIERS IN MICROBIOLOGY (2016)
EFFECT OF RpoN, RpoS AND LuxS PATHWAYS ON THE BIOFILM FORMATION AND ANTIBIOTIC SENSITIVITY OF BORRELIA BURGDORFERI
Eva Sapi et al.
EUROPEAN JOURNAL OF MICROBIOLOGY AND IMMUNOLOGY (2016)
Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells
Bijaya Sharma et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Drug Combinations against Borrelia burgdorferi Persisters In Vitro: Eradication Achieved by Using Daptomycin, Cefoperazone and Doxycycline
Jie Feng et al.
PLOS ONE (2015)
Incidence of Clinician-Diagnosed Lyme Disease, United States, 2005-2010
Christina A. Nelson et al.
EMERGING INFECTIOUS DISEASES (2015)
Identification of Additional Anti-Persister Activity against Borrelia burgdorferi from an FDA Drug Library
Jie Feng et al.
ANTIBIOTICS-BASEL (2015)
Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library
Jie Feng et al.
EMERGING MICROBES & INFECTIONS (2014)
In vitro susceptibility of European human Borrelia burgdorferi sensu stricto strains to antimicrobial agents
Gorana Veinovic et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
The expanding Lyme Borrelia complex-clinical significance of genomic species?
G. Stanek et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Prevalence of Antimicrobial-Resistant Pathogens in Canadian Hospitals: Results of the Canadian Ward Surveillance Study (CANWARD 2008)
George G. Zhanel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Comparison of in vitro activities of tigecycline, doxycycline, and tetracycline against the spirochete Borrelia burgdorferi
Louis Ates et al.
TICKS AND TICK-BORNE DISEASES (2010)
In Vitro Susceptibility of Borrelia spielmanii to Antimicrobial Agents Commonly Used for Treatment of Lyme Disease
Kristina Morgenstern et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Comparative In Vitro Activity of Tigecycline and Nine Other Antibiotics Against Gram-Negative Bacterial Isolates, Including ESBL-Producing Strains
W. Y. Jamal et al.
JOURNAL OF CHEMOTHERAPY (2009)
Changes in the expression pattern of structural proteins after exposure of Borrelia burgdorferi to penicillin G and doxycycline
Klaus-Peter Hunfeld et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2008)
Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new Species Borrelia spielmanii sp nov.
Volker Fingerle et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2008)
An RND-type efflux system in Borrelia burgdorferi is involved in virulence and resistance to antimicrobial compounds
Ignas Bunikis et al.
PLOS PATHOGENS (2008)
In vitro activities of faropenem, ertapenem, imipenem and meropenem against Borrelia burgdorferi s.l.
Rebecca Roedel et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Antimicrobial susceptibility of Borrelia burgdorferi sensu lato:: What we know, what we don't know, and what we need to know
Klaus-Peter Hunfeld et al.
WIENER KLINISCHE WOCHENSCHRIFT (2006)
Risk of culture-confirmed borrelial persistence in patients treated for erythema migrans and possible mechanisms of resistance
Klaus-Peter Hunfeld et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2006)
Mutations conferring aminoglycoside and spectinomycin resistance in Borrelia burgdorferi
D Criswell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
parC mutations in fluoroquinolone-resistant Borrelia burgdorfeti
KM Galbraith et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Susceptibility of Borrelia afzelii strains to antimicrobial agents
E Ruzic-Sabljic et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
In vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy
KP Hunfeld et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Novel resistance-nodulation-cell division efflux system AdeDE in Acinetobacter genomic DNA group 3
SL Chau et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Macrolide resistance in Treponema pallidum in the United States and Ireland
SA Lukehart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The glycylcyclines - A comparative review with the tetracyclines
GG Zhanel et al.
DRUGS (2004)
Comparison of in vitro activities of ketolides, macrolides, and an azalide against the spirochete Borrelia burgdorferi
KP Hunfeld et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Duration of antibiotic therapy for early Lyme disease - A randomized, double-blind, placebo-controlled trial
GP Wormser et al.
ANNALS OF INTERNAL MEDICINE (2003)
In vitro susceptibility testing of four antibiotics against Borrelia burgdorferi:: a comparison of results for the three genospecies Borrelia afzelii, Borrelia garinii, and Borrelia burgdorferz sensu stricto
M Sicklinger et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
In vitro activity of eight oral cephalosporins against Borrelia burgdorferi
KP Hunfeld et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2003)
Prevalence and persistence of asymptomatic Chlamydia trachomatis infections in urine specimens from Danish male military recruits
AJC van den Brule et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2002)
Diffusion of β-lactam antibiotics through oligomeric or monomeric porin channels of some gram-negative bacteria
Y Nitzan et al.
CURRENT MICROBIOLOGY (2002)
Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment
LK Bockenstedt et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Erythromycin resistance in Borrelia burgdorferi
D Terekhova et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Standardised in vitro susceptibility testing of Borrelia burgdorferi against well-known and newly developed antimicrobial agents -: Possible implications for new therapeutic approaches to Lyme disease
KP Hunfeld et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2002)
Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans
RP Smith et al.
ANNALS OF INTERNAL MEDICINE (2002)
In vitro activities of fluoroquinolones against the spirochete Borrelia burgdorferi
P Kraiczy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
In vitro susceptibility of the Borrelia burgdorferi sensu lato complex to ABT-773, a novel ketolide
KP Hunfeld et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Medical progress: Lyme disease.
AC Steere
NEW ENGLAND JOURNAL OF MEDICINE (2001)
In vitro activity of mezlocillin, meropenem, aztreonam, vancomycin, teicoplanin, ribostamycin and fusidic acid against Borrelia burgdorferi
KP Hunfeld et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2001)
Isolation and polymerase chain reaction typing of Borrelia afzelii from a skin lesion in a seronegative patient with generalized ulcerating bullous lichen sclerosus et atrophicus
F Breier et al.
BRITISH JOURNAL OF DERMATOLOGY (2001)
Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections
HM Yassin et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2001)
ABT-773: a new ketolide antibiotic
TJ Dougherty et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2001)
Practice guidelines for the treatment of Lyme disease
GP Wormser et al.
CLINICAL INFECTIOUS DISEASES (2000)
Failure of treatment with cephalexin for Lyme disease
J Nowakowski et al.
ARCHIVES OF FAMILY MEDICINE (2000)
Colorimetric in vitro susceptibility testing of penicillins, cephalosporins, macrolides, streptogramins, tetracyclines, and aminoglycosides against Borrelia burgdorferi isolates
KP Hunfeld et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2000)
Studies of the novel ketolide ABT-773:: Transport, binding to ribosomes, and inhibition of protein synthesis in Streptococcus pneumoniae
JO Capobianco et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
The Lyme disease vaccine: Conception, development, and implementation
WT Thanassi et al.
ANNALS OF INTERNAL MEDICINE (2000)
Purification of pneumococcal type II topoisomerases and inhibition by gemifloxacin and other quinolones
I Morrissey et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Serum-starvation-induced changes in protein synthesis and morphology of Borrelia burgdorferi
PS Alban et al.
MICROBIOLOGY-SGM (2000)
New colorimetric microdilution method for in vitro susceptibility testing of Borrelia burgdorferi against antimicrobial substances
KP Hunfeld et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2000)
分享论文
